Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator sensitive to cannabinoids and opioids in hippocampal CA1

Journal of Physiology

Volumn 592, Issue 1, 2014, Pages 103-123

  Nagode, Daniel A ^a,b   Tang, Ai Hui ^a   Yang, Kun ^a   Alger, Bradley E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b University of Maryland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ARCHAERHODOPSIN; CANNABINOID; CANNABINOID 1 RECEPTOR; CARBACHOL; CHOLECYSTOKININ; CHOLINERGIC RECEPTOR STIMULATING AGENT; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID DECARBOXYLASE 2; HALORHODOPSIN; MU OPIATE RECEPTOR AGONIST; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; OPIATE; PARVALBUMIN; RHODOPSIN; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ACETYLCHOLINE RELEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CHOLINERGIC STIMULATION; COGNITION; CONTROLLED STUDY; GABAERGIC TRANSMISSION; GENE SILENCING; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IN VITRO STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MOUSE; NEOCORTEX; NERVE CELL INHIBITION; NERVE CELL NETWORK; NERVE FIBER; NEUROMODULATION; NONHUMAN; OPTOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PYRAMIDAL NERVE CELL; RAT; SENSORY NERVE; THETA RHYTHM;

ANALGESICS, OPIOID; ANIMALS; CA1 REGION, HIPPOCAMPAL; CANNABINOIDS; CHOLECYSTOKININ; CHOLINERGIC NEURONS; GLUTAMATE DECARBOXYLASE; INHIBITORY POSTSYNAPTIC POTENTIALS; INTERNEURONS; MICE; OPSINS; OPTOGENETICS; PARVALBUMINS; THETA RHYTHM;

EID: 84891372270     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.257428     Document Type: Article

References (79)

1. Alger BE (2002). Retrograde signalling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68, 247-286.
2. Alger BE, Pitler TA, Wagner JJ, Martin LA, Morishita W, Kirov SA & Lenz RA (1996). Retrograde signalling in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J Physiol 496, 197-209.
3. Atasoy D, Aponte Y, Su HH & Sternson SM (2008). A FLEX switch targets channelrhodopsin-2 to multiple cell types for imaging and long-range circuit mapping. J Neurosci 28, 7025-7030.
4. Bartos M & Elgueta C (2012). Functional characteristics of parvalbumin- and cholecystokinin-expressing basket cells. J Physiol 590, 669-681.
5. Bell KA, Shim H, Chen CK & McQuiston AR (2011). Nicotinic excitatory postsynaptic potentials in hippocampal CA1 interneurons are predominantly mediated by nicotinic receptors that contain alpha4 and beta2 subunits. Neuropharmacology 61, 1379-1388.
6. Bender KJ, Ford CP & Trussell LO (2010). Dopaminergic modulation of axon initial segment calcium channels regulates action potential initiation. Neuron 68, 500-511.
7. Buhl EH, Tamás G & Fisahn A (1998). Cholinergic activation and tonic excitation induce persistent gamma oscillations in mouse somatosensory cortex in vitro. J Physiol 513, 117-126.
8. Cea-del Rio CA, Lawrence JJ, Tricoire L, Erdelyi F, Szabo G & McBain CJ (2010). M3 muscarinic acetylcholine receptor expression confers differential cholinergic modulation to neurochemically distinct hippocampal basket cell subtypes. J Neurosci 30, 6011-6024.
9. Cea-del Rio CA, McBain CJ & Pelkey KA (2012). An update on cholinergic regulation of cholecystokinin-expressing basket cells. J Physiol 590, 695-702.
10. Chapman CA & Lacaille JC (1999). Cholinergic induction of theta-frequency oscillations in hippocampal inhibitory interneurons and pacing of pyramidal cell firing. J Neurosci 19, 8637-8645.
11. Choi VW, McCarty DM & Samulski RJ (2005). AAV hybrid serotypes: improved vectors for gene delivery. Curr Gene Ther 5, 299-310.
12. Chow BY, Han X, Dobry AS, Qian X, Chuong AS, Li M, Henninger MA, Belfort GM, Lin Y, Monahan PE & Boyden ES (2010). High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature 463, 98-102.
13. Christie MJ (2006). Opioid and cannabinoid receptors: friends with benefits or just close friends Br J Pharmacol 148, 385-386.
14. Cobb SR & Davies CH (2005). Cholinergic modulation of hippocampal cells and circuits. J Physiol 562, 81-88.
15. Diana MA & Marty A (2003). Characterization of depolarization-induced suppression of inhibition using paired interneuron-Purkinje cell recordings. J Neurosci 23, 5906-5918.
16. Drake CT & Milner TA (2002). Mu opioid receptors are in discrete hippocampal interneuron subpopulations. Hippocampus 12, 119-136.
17. Dugladze T, Schmitz D, Whittington MA, Vida I & Gloveli T (2013). Segregation of axonal and somatic activity during fast network oscillations. Science 336, 1458-1461.
18. Ellender TJ & Paulsen O (2010). The many tunes of perisomatic targeting interneurons in the hippocampal network. Front Cell Neurosci 4, 1-11.
19. Fisahn A, Pike FG, Buhl EH & Paulsen O (1998). Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro. Nature 394, 186-189.
20. Foldy C, Neu A, Jones MV & Soltesz I (2006). Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci 26, 1465-1469.
21. Fortin DA, Trettel J & Levine ES (2004). Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J Neurophysiol 92, 2105-2112.
22. Franklin K & Paxinos G (1997). The Mouse Brain in Stereotaxic Coordinates. Academic Press.
23. Freund TF & Buzsaki G (1996). Interneurons of the hippocampus. Hippocampus 6, 347-470.
24. Freund TF & Katona I (2007). Perisomatic inhibition. Neuron 56, 33-42.
25. Freund TF, Katona I & Piomelli D (2003). Role of endogenous cannabinoids in synaptic signalling. Physiol Rev 83, 1017-1066.
26. Fuentealba P, Begum R, Capogna M, Jinno S, Marton LF, Csicsvari J, Thompson A, Somogyi P & Klausberger T (2008). Ivy cells: a population of nitric-oxide-producing, slow-spiking GABAergic neurons and their involvement in hippocampal network activity. Neuron 57, 917-929.
27. Galarreta M, Erdélyi F, Szabó G & Hestrin S (2004). Electrical coupling among irregular-spiking GABAergic interneurons expressing cannabinoid receptors. J Neurosci 24, 9770-9778.
28. Gillies MJ, Traub RD, LeBeau FE, Davies CH, Gloveli T, Buhl EH & Whittington MA (2002). A model of atropine-resistant theta oscillations in rat hippocampal area CA1. J Physiol 543, 779-793.
29. Glickfeld LL, Atallah BV & Scanziani, M (2008). Complementary modulation of somatic inhibition by opioids and cannabinoids. J Neurosci 28, 1824-1832.
30. Gu Z & Yakel JL (2011). Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity. Neuron 71, 155-165.
31. Gulyas AI, Szabo GG, Ulbert I, Holderith N, Monyer H, Erdelyi F, Szabo G, Freund TF & Hajos N (2010). Parvalbumin-containing fast-spiking basket cells generate the field potential oscillations induced by cholinergic receptor activation in the hippocampus. J Neurosci 30, 15134-15145.
32. Hajos N, Papp EC, Acsady L, Levey AI & Freund TF (1998). Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience 82, 355-376.
33. Hampson RE, Zhuang SY, Weiner JL & Deadwyler SA (2003). Functional significance of cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the hippocampus. J Neurophysiol 90, 55-64.
34. Hefft S & Jonas P (2005). Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat Neurosci 8, 1319-1328.
35. Holderith N, Nemeth B, Papp OI, Veres JM, Nagy GA & Hajos N (2011). Cannabinoids attenuate hippocampal gamma oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells. J Physiol 589, 4921-4934.
36. Hojo M, Sudo Y, Ando Y, Minami K, Takada M, Matsubara T, Kanaide M, Taniyama K, Sumikawa K & Uezono Y (2008). mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis. J Pharmacol Sci 108, 308-319.
37. Jones S & Yakel JL (1997). Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J Physiol 504, 603-610.
38. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M & Watanabe M (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89, 309-380.
39. Karson MA, Tang AH, Milner TA & Alger BE (2009). Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus. J Neurosci 29, 4140-4154.
40. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K & Freund TF (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19, 4544-4558.
41. Kim J, Isokawa M, Ledent C & Alger BE (2002). Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22, 10182-10191.
42. 2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro. Br J Pharmacol 105, 470-474.
43. Klausberger T & Somogyi P (2008). Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321, 53-57.
44. Krook-Magnuson E, Luu L, Lee SH, Varga C & Soltesz I (2011). Ivy and neurogliaform interneurons are a major target of muopioid receptor modulation. J Neurosci 31, 14861-14870.
45. Lafourcade CA & Alger BE (2008). Distinctions among GABAA and GABAB responses revealed by calcium channel antagonists, cannabinoids, opioids, and synaptic plasticity in rat hippocampus. Psychopharmacology 198, 539-549
46. Lawrence J (2008). Cholinergic control of GABA release: emerging parallels between neocortex and hippocampus. Trends Neurosci 31, 317-327.
47. Lenz RA, Wagner JJ & Alger BE (1998). N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J Physiol 512, 61-73.
48. López-Bendito G, Sturgess K, Erdélyi F, Szabó G, Molnár Z & Paulsen O (2004). Preferential origin and layer destination of GAD65-GFP cortical interneurons. Cereb Cortex 14, 1122-1133.
49. Losonczy A, Biró AA & Nusser Z (2004). Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc Natl Acad Sci USA 101, 1362-1367.
50. Mann EO, Tominaga T, Ichikawa M & Greenfield SA (2005). Cholinergic modulation of the spatiotemporal pattern of hippocampal activity in vitro. Neuropharmacology 48, 118-133.
51. Marsicano G & Lutz B (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11, 4213-4225.
52. Martin LA & Alger BE (1999). Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus. Neuroscience 92, 61-71.
53. Martin LA, Wei DS & Alger BE (2001). Heterogeneous susceptibility of GABA(A) receptor-mediated IPSCs to depolarization-induced suppression of inhibition in rat hippocampus. J Physiol 532, 685-700.
54. McQuiston AR & Madison DV (1999a). Muscarinic receptor activity has multiple effects on the resting membrane potentials of CA1 hippocampal interneurons. J Neurosci 19, 5693-5702.
55. McQuiston AR & Madison DV (1999b). Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus. J Neurosci 19, 2887-2896.
56. Morishita W, Kirov SA & Alger BE (1998). Evidence for metabotropic glutamate receptor activation in the induction of depolarization-induced suppression of inhibition in hippocampal CA1. J Neurosci 18, 4870-4882.
57. Nagode DA, Tang A-H, Karson MA, Klugmann M & Alger BE (2011). Optogenetic release of ACh induces rhythmic bursts of perisomatic IPSCs in hippocampus. PloS One 6, e27691.
58. Neu A, Foldy C & Soltesz I (2007). Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J Physiol 578, 233-247.
59. Ohno-Shosaku T, Maejima T & Kano M (2001). Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29, 729-738.
60. Ohno-Shosaku T, Matsui M, Fukudome Y, Shosaku J, Tsubokawa H, Taketo MM, Manabe T & Kano M (2003). Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci 8, 109-116.
61. Oren I, Hajos N & Paulsen O (2010). Identification of the current generator underlying cholinergically induced gamma frequency field potential oscillations in the hippocampal CA3 region. J Physiol 588, 785-797.
62. Oren I, Mann EO, Paulsen O & Hajos N (2006). Synaptic currents in anatomically identified CA3 neurons during hippocampal gamma oscillations in vitro. J Neurosci 26, 9923-9934.
63. Petreanu L, Huber D, Sobczyk A & Svoboda K (2007). Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections. Nat Neurosci 10, 663-668.
64. Pitler TA & Alger BE (1992a). Cholinergic excitation of GABAergic interneurons in the rat hippocampal slice. J Physiol 450, 127-142.
65. Pitler TA & Alger BE (1992b). Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci 12, 4122-4132.
66. Pitler TA & Alger BE (1994). Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron 13, 1447-1455.
67. Reich CG, Karson MA, Karnup SV, Jones LM & Alger BE (2005). Regulation of IPSP theta rhythm by muscarinic receptors and endocannabinoids in hippocampus. J Neurophysiol 94, 4290-4299.
68. Robbe D, Montgomery SM, Thome A, Rueda-Orozco PE, McNaughton BL & Buzsaki, G (2006). Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci 9, 1526-1533.
69. Rodriguez JJ, Mackie K & Pickel VM (2001). Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. J Neurosci 21, 823-833.
70. Royer S, Zemelman BV, Losonczy A, Kim J, Chance F, Magee JC & Buzsaki G (2012). Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition. Nat Neurosci 15, 769-775.
71. 2+ release from stores. J Neurosci 31, 13546-13561.
72. Trettel J, Fortin DA & Levine ES (2004). Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol 556, 95-107.
73. Tricoire L, Pelkey KA, Erkkila BE, Jeffries BW, Yuan X & McBain CJ (2011). A blueprint for the spatiotemporal origins of mouse hippocampal interneuron diversity. J Neurosci 31, 10948-10970.
74. Widmer H, Ferrigan L, Davies CH & Cobb SR (2006). Evoked slow muscarinic acetylcholinergic synaptic potentials in rat hippocampal interneurons. Hippocampus 16, 617-628.
75. Wilson RI, Kunos G & Nicoll RA (2001). Presynaptic specificity of endocannabinoid signalling in the hippocampus. Neuron 31, 453-462.
76. Wilson RI & Nicoll RA (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588-592.
77. Wulff P, Ponomarenko AA, Bartos M, Korotkova TM, Fuchs EC, Bähner F, Both M, Tort AB, Kopell NJ, Wisden W & Monyer H (2009). Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons. Proc Natl Acad Sci USA 106, 3561-3566.
78. Yoshino H, Miyamae T, Hansen G, Zambrowicz B, Flynn M, Pedicord D, Blat Y, Westphal RS, Zaczek R, Lewis DA & Gonzalez-Burgos G (2011). Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J Physiol 589, 4857-4884.
79. Zhang F, Wang LP, Brauner M, Liewald JF, Kay K, Watzke N, Wood PG, Bamberg E, Nagel G, Gottschalk A & Deisseroth K (2007). Multimodal fast optical interrogation of neural circuitry. Nature 446, 633-639.